These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Hemocomponent therapy of central involution chorioretinal dystrophy].
    Author: Mukha AI, Lysenko VS, Galileeva VV, Andreeva LD, Markova OA.
    Journal: Vestn Oftalmol; 1998; 114(1):28-31. PubMed ID: 9584636.
    Abstract:
    Hemocomponent therapy was used in 181 patients (347 eyes) with central chorioretinal dystrophy. Activated autoplasma possessing a marked resorptive effect, consisting in resorption of hemorrhages and exudations on the fundus oculi, was used. Vision acuity improved in 75% of examined eyes by an average of 0.2 diopters.
    [Abstract] [Full Text] [Related] [New Search]